|
業務類別
|
Diagnostics & Research |
|
業務概覽
|
BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates(QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response. |
| 公司地址
| 1035 O’Brien Drive, Menlo Park, CA, USA, 94025 |
| 電話號碼
| +1 650 460-2551 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.billiontoone.com |
| 員工數量
| 713 |
| Mr. John D. Lister |
Chief Administrative Officer |
美元 182.98K |
21/04/2026 |
| Mr. Ross Taylor |
Chief Financial Officer and Principal Accounting Officer |
-- |
21/04/2026 |
| Mr. Thomas P. Lynch |
General Counsel, Chief Compliance Officer and Secretary |
-- |
21/04/2026 |
| Dr. Oguzhan Atay, PhD |
Chief Executive Officer and Chairman of the Board |
美元 371.81K |
21/04/2026 |
| Dr. David Tsao, PhD |
President, Chief Technology Officer and Director |
美元 332.94K |
21/04/2026 |
| Dr. John ten Bosch, PhD |
Senior Vice President, Laboratory Operations |
-- |
21/04/2026 |
| Ms. Nancy JoAnn Johnson |
Senior Vice President, Sales and Commercial Operations |
-- |
21/04/2026 |
| Ms. Shan Riku Sakakibara |
Chief Product Officer |
-- |
21/04/2026 |
|
|
| Mr. Anthony Pagano |
Independent Director |
21/04/2026 |
| Dr. Oguzhan Atay, PhD |
Chief Executive Officer and Chairman of the Board |
21/04/2026 |
| Dr. David Tsao, PhD |
President, Chief Technology Officer and Director |
21/04/2026 |
| Mr. Akshay Rai |
Independent Director |
21/04/2026 |
| Mr. Krishna Swaroop Kolluri |
Independent Director |
21/04/2026 |
| Mr. Firat Ileri |
Lead Independent Director |
21/04/2026 |
| Mr. Thomas S Bremner |
Independent Director |
21/04/2026 |
|
|
|
|
